alzheimer's semaglutide Details of failed studies cast pall on Novo Nordisk's GLP-1 as treatment A Critical Appraisal of the
Description
Congratulations Lindsay Zasadzinski, MPH, Tamkeen Khan, PhD, Greg Wozniak, Jianing Yang, Stavros Tsipas & Susan Sutherland, MS, PhD To view or add a comment, sign in 14,499 followers

Biologically, heres what happens: when you burn more energy than youre feeding your body, your body looks for alternative fuel sourcesspecifically, your stored fat

Research published in clinical trials of semaglutide shows that up to 40% of total weight lost can be lean muscle mass when protein intake is insufficient

The goal is to create a sustainable long-term plan that supports lasting wellness while minimizing the risk of weight regain
